Effective axillary malodour reduction by polyquaternium‐16‐containing deodorants
Authors:
Open Access
- 13 September 2016
- journal article
- research article
- Published by Wiley in International Journal of Cosmetic Science
- Vol. 39 (2) , 141-148
Abstract
Objective: Worldwide, individuals apply deodorants to combat malodour formation originating from the axillary vault. Considering the globally increasing demand for efficacious, safe deodorants, we investigated the antimicrobial effectiveness of a polymeric quaternary ammonium compound (PQ‐16) as a new active in a roll‐on formulation against microbial growth and axillary malodour.Methods: We utilized an in vivo microbiological assessment to determine antimicrobial effects of the PQ‐16‐containing deodorant formulation (DEO1) (i) in comparison with a commercially available deodorant roll‐on claiming a 24‐h protection against body odour (DEO2) and (ii) in comparison with a roll‐on containing the same formulation as DEO1 but comprising aluminium chlorohydrate instead of PQ‐16 (DEO3) 1, 4, 8, 24 and 48 h after treatment. Also, the axillary malodour intensity 24 and 48 h after application of deodorants was investigated in a controlled in vivo study performed by a trained sniffer panel using direct sniffing.Results: Treatment with DEO1 in comparison with application of DEO2 significantly reduced the log 10 bacterial count at all points in time. After 24 and 48 h, sniffers rated malodour production in the DEO1‐treated axillae significantly lower than in the DEO2‐treated armpits. Application of DEO1 in comparison with DEO3 decreased the log 10 bacterial count after 1, 4, 8 and 24 h (significant for 4 and 8 h). After 48 h, the log 10 bacterial count showed similar values for both DEO1 and DEO3. The sniffer panel reported no significant differences between axillary malodour in DEO1‐treated compared to DEO3‐treated armpits after 24 and 48 h.Conclusion: We identified polyquaternium‐16 (PQ‐16, copolymers of 1‐vinyl‐2‐pyrrolidone and 1‐vinyl‐3‐methylimidazolium chloride) as a highly effective deodorant active. Results showed that a newly developed PQ‐16‐containing deodorant roll‐on formulation (i) significantly reduced axillary malodour 24 and 48 h after treatment, (ii) significantly decreased the amount of axillary bacteria, (iii) compared to a commercially available deodorant claiming a 24‐h odour protection significantly lowered axillary malodour 24 h and 48 h after application, and (iv) was well tolerated by the study population. PQ‐16 represents an innovative and skin‐friendly deodorant active.Keywords
Funding Information
- Beiersdorf AG
This publication has 26 references indexed in Scilit:
- Characterization of Staphylococcus and Corynebacterium Clusters in the Human Axillary RegionPLOS ONE, 2013
- Cationic Antimicrobial Polymers and Their AssembliesInternational Journal of Molecular Sciences, 2013
- Body malodours and their topical treatment agentsInternational Journal of Cosmetic Science, 2011
- Topographical and Temporal Diversity of the Human Skin MicrobiomeScience, 2009
- Design and application of a screening and training protocol for odour testers in the field of personal care productsInternational Journal of Cosmetic Science, 2009
- Body odour of monozygotic human twins: a common pattern of odorant carboxylic acids released by a bacterial aminoacylase from axilla secretions contributing to an inherited body odour typeJournal of The Royal Society Interface, 2008
- A short history of sweat gland biologyInternational Journal of Cosmetic Science, 2007
- EEMCO Guidance for the Efficacy Assessment of Antiperspirants and DeodorantsSkin Pharmacology and Physiology, 2003
- Biology of sweat glands and their disorders. I. Normal sweat gland functionJournal of the American Academy of Dermatology, 1989
- Odor-guided behavior in mammalsCellular and Molecular Life Sciences, 1986